Can pharmacotherapy help persistent genital arousal disorder?

Expert Opinion on Pharmacotherapy
Tillmann H C Kruger

Abstract

Persistent genital arousal disorder (PGAD) is a presumably rare, although debilitating condition, which was first defined only at the beginning of this century and has not yet found consideration by any of the international classification systems of diseases. As affected patients can suffer tremendously, this report aims at providing an overview and an expert opinion on the few existing studies and case reports, guiding clinicians in the treatment and pharmacotherapy of PGAD. Areas covered: In this article case reports, case series and surveys on drugs that may both alleviate or worsen/induce PGAD are reported. Expert opinion: Data on pharmacological treatment options in PGAD are sparse and mainly rely on case reports making conclusions difficult. Most importantly, some drugs such as serotonin reuptake inhibitors (SSRIs) may even induce or worsen PGAD during treatment or withdrawal. We now need an initial spark in order to promote basic research on the etiology of PGAD as well as clinical trials on possible treatment options. In the meanwhile, clinicians should provide careful diagnostics and counseling for affected patients. In case pharmacotherapy is desired, drugs that are able to inhibit sexual excitation and/or modulate se...Continue Reading

References

Oct 1, 1989·Journal of Clinical Psychopharmacology·J G ModellT P Beresford
Mar 1, 1997·International Clinical Psychopharmacology·M Berk, M Acton
Jul 10, 2001·Journal of Sex & Marital Therapy·S R Leiblum, S G Nathan
Jan 21, 2006·The Journal of Sexual Medicine·Linda Freed
Feb 24, 2006·The Journal of Sexual Medicine·Kevan WylieAmanda Goddard
Dec 13, 2006·Journal of Sex & Marital Therapy·Sheila Mahoney, Carlos Zarate
Jan 29, 2008·Journal of Sex & Marital Therapy·Sandra R Leiblum, David Goldmeier
May 20, 2009·International Journal of STD & AIDS·D GoldmeierUNKNOWN BASHH Special Interest Group for Sexual Dysfunction
Aug 14, 2009·The Journal of Sexual Medicine·Cesare Battaglia, Stefano Venturoli
Oct 20, 2010·The Journal of Sexual Medicine·Marcel D WaldingerDave H Schweitzer
Oct 26, 2011·The Journal of Sexual Medicine·Susanne Philippsohn, Tillmann H C Kruger
Mar 29, 2013·The Journal of Sexual Medicine·Joana CarvalhoPedro J Nobre
Dec 18, 2013·Journal of Sex & Marital Therapy·Joana CarvalhoPedro J Nobre
May 7, 2014·Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'obstétrique Et Gynécologie Du Canada : JOGC·Leah PinkAllan Gordon
Oct 7, 2014·JAMA Neurology·Camila C AquinoAnthony E Lang
May 1, 2015·Journal of Clinical Psychopharmacology·Frederico José Coelho de Magalhães, Manoj Therayil Kumar
Jun 3, 2015·Journal of Sex & Marital Therapy·Tillmann H C Kruger, Uwe Hartmann
Oct 11, 2015·International Journal of Dermatology·Farzaneh Agha-Hosseini, Nafiseh Sheykhbahaei
Nov 26, 2015·Indian Journal of Psychiatry·Kamala DekaRina Ahmed
Jul 12, 2016·Obstetrics and Gynecology·Christina L JonesSandra L Hernandez
Jul 17, 2016·The Australian and New Zealand Journal of Psychiatry·Konstantinos N FountoulakisVasilios Kimiskidis
Aug 30, 2016·Indian Journal of Psychological Medicine·Manju AswathRaguram Ramnath
Nov 16, 2016·The Journal of Sexual Medicine·Sharon J ParishBeverly Whipple
Nov 29, 2016·Journal of Sex & Marital Therapy·Abby Girard, Scott R Woolley
Feb 1, 2017·Epilepsy & Behavior : E&B·Rocco Salvatore Calabrò
Jun 22, 2017·Journal of Psychosomatic Obstetrics and Gynaecology·Ejder Akgun YildirimIrmak Sarac
Jun 29, 2017·Female Pelvic Medicine & Reconstructive Surgery·Natalie GainesKenneth M Peters
Jul 22, 2017·Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine·Emilia SforzaFrédéric Roche
Aug 6, 2017·Sexual Medicine Reviews·Areeg BalaWayne J G Hellstrom
Apr 11, 2018·Clinical Neuropharmacology·Keita MiyakeNorihito Yamada
Apr 21, 2018·Endocrine·Silvia GiattiRoberto Cosimo Melcangi
May 8, 2018·The International Journal of Risk & Safety in Medicine·David HealyDerelie Mangin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.